146 related articles for article (PubMed ID: 37728077)
1. Should we be screening for COPD? - looking through the lens of lung cancer screening.
Young RP; Scott RJ
Expert Rev Respir Med; 2023; 17(9):753-771. PubMed ID: 37728077
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
[TBL] [Abstract][Full Text] [Related]
4. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.
Hopkins RJ; Duan F; Chiles C; Greco EM; Gamble GD; Aberle D; Young RP
Ann Am Thorac Soc; 2017 Mar; 14(3):392-402. PubMed ID: 28076701
[TBL] [Abstract][Full Text] [Related]
5. Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry.
Tisi S; Dickson JL; Horst C; Quaife SL; Hall H; Verghese P; Gyertson K; Bowyer V; Levermore C; Mullin AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; ; Hurst JR; Janes SM
Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35896207
[TBL] [Abstract][Full Text] [Related]
6. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.
Weiss G; Steinacher I; Lamprecht B; Kaiser B; Mikes R; Sator L; Hartl S; Wagner H; Studnicka M
NPJ Prim Care Respir Med; 2017 Jan; 27(1):4. PubMed ID: 28127061
[TBL] [Abstract][Full Text] [Related]
8. Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study.
Tamaki K; Sakihara E; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R; Kaise T
Int J Chron Obstruct Pulmon Dis; 2021; 16():1771-1782. PubMed ID: 34168439
[TBL] [Abstract][Full Text] [Related]
9. Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.
Kaaks R; Christodoulou E; Motsch E; Katzke V; Wielpütz MO; Kauczor HU; Heussel CP; Eichinger M; Delorme S
Transl Lung Cancer Res; 2022 Sep; 11(9):1896-1911. PubMed ID: 36248328
[TBL] [Abstract][Full Text] [Related]
10. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
[TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
[TBL] [Abstract][Full Text] [Related]
12. Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters.
Young RP; Ward RC; Scott RJ; Gamble GD; Silvestri G
Thorax; 2023 Jul; 78(7):690-697. PubMed ID: 36456179
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
Cadham CJ; Oh H; Han MK; Mannino D; Cook S; Meza R; Levy DT; Sánchez-Romero LM
Respir Res; 2024 May; 25(1):208. PubMed ID: 38750492
[TBL] [Abstract][Full Text] [Related]
14. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
[TBL] [Abstract][Full Text] [Related]
15. Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm).
Wei X; Ding Q; Yu N; Mi J; Ren J; Li J; Xu S; Gao Y; Guo Y
Lung; 2018 Dec; 196(6):649-658. PubMed ID: 30218155
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
Stav D; Raz M
Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of airflow limitation on medical check-up in Japanese subjects.
Omori H; Nonami Y; Mihara S; Marubayashi T; Morimoto Y; Aizawa H
J UOEH; 2007 Sep; 29(3):209-19. PubMed ID: 17900001
[TBL] [Abstract][Full Text] [Related]
19. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
